Business Description
Incannex Healthcare Inc
NAICS : 325412
SIC : 2833
ISIN : US45333F1093
Share Class Description:
IXHL: ADRTotal Employee Number:
12Description
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 653.07 | |||||
Equity-to-Asset | 0.94 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -240.3 | |||||
3-Year EPS without NRI Growth Rate | 42.2 | |||||
3-Year FCF Growth Rate | -130.7 | |||||
3-Year Book Growth Rate | -66.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 61.62 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.96 | |||||
9-Day RSI | 47.61 | |||||
14-Day RSI | 49.24 | |||||
3-1 Month Momentum % | -7.21 | |||||
6-1 Month Momentum % | -19.1 | |||||
12-1 Month Momentum % | -81.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 41.56 | |||||
Quick Ratio | 41.56 | |||||
Cash Ratio | 38.64 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -146.8 | |||||
Shareholder Yield % | -187.29 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -20620.93 | |||||
OCF Margin % | -20608.14 | |||||
ROE % | -98.23 | |||||
ROA % | -89.44 | |||||
ROIC % | -705.03 | |||||
3-Year ROIIC % | -2231.02 | |||||
ROC (Joel Greenblatt) % | -12986.05 | |||||
ROCE % | -96.37 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 3.86 | |||||
PS Ratio | 44.18 | |||||
PB Ratio | 0.6 | |||||
Price-to-Tangible-Book | 0.6 | |||||
EV-to-EBIT | 0.72 | |||||
EV-to-EBITDA | 0.72 | |||||
EV-to-Forward-EBITDA | 0.12 | |||||
EV-to-Revenue | -403.41 | |||||
EV-to-Forward-Revenue | 0.06 | |||||
EV-to-FCF | 1.96 | |||||
| Price-to-Net-Current-Asset-Value | 0.6 | |||||
| Price-to-Net-Cash | 0.65 | |||||
Earnings Yield (Greenblatt) % | 138.89 | |||||
FCF Yield % | -44.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IXHL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Incannex Healthcare Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.086 | ||
| EPS (TTM) ($) | -6.428 | ||
| Beta | 5.0191 | ||
| 3-Year Sharpe Ratio | -0.21 | ||
| 3-Year Sortino Ratio | -0.37 | ||
| Volatility % | 90.17 | ||
| 14-Day RSI | 49.24 | ||
| 14-Day ATR ($) | 0.183166 | ||
| 20-Day SMA ($) | 3.408125 | ||
| 12-1 Month Momentum % | -81.93 | ||
| 52-Week Range ($) | 2.49 - 20.313 | ||
| Shares Outstanding (Mil) | 11.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Incannex Healthcare Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Incannex Healthcare Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2027-02-12 | In 156 days | ||
| General meeting for 2026 | 2026-12-18 01:00 | In 101 days | ||
| Annual report for 2026 | 2026-09-29 | In 20 days | ||
| Third quarter earnings results for 2026 | 2026-05-15 | 3.88 (+0.78%) | ||
| 0.0333333:1 Stock Split | 2026-02-27 | 5.01 (+6.78%) | ||
| Second quarter earnings results for 2026 | 2026-02-13 | 8.07 (-4.07%) | ||
| General meeting for 2025 | 2025-12-18 01:00 | 12.34 (-2.05%) | ||
| Annual report for 2025 | 2025-09-29 | 17.85 (+0.78%) | ||
| Third quarter earnings results for 2025 | 2025-05-15 | 21.00 (+96.30%) | ||
| Second quarter earnings results for 2025 | 2025-02-14 | 53.92 (+5.10%) |
Show
Entries
Incannex Healthcare Inc Frequently Asked Questions
What is Incannex Healthcare Inc(IXHL)'s stock price today?
The current price of IXHL is $3.31. The 52 week high of IXHL is $20.31 and 52 week low is $2.49.
When is next earnings date of Incannex Healthcare Inc(IXHL)?
The next earnings date of Incannex Healthcare Inc(IXHL) is .
Does Incannex Healthcare Inc(IXHL) pay dividends? If so, how much?
Incannex Healthcare Inc(IXHL) does not pay dividend.
Press Release
Articles on Incannex Healthcare Inc
Incannex Healthcare (IXHL) Secures A$5.1M R&D Tax Refund, Highlighting Cash Flow Challenges
Aug 11, 2026
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers